```html

X‑ray Dermatitis: A Complete Patient Guide

What is X‑ray Dermatitis?

X‑ray dermatitis (also called radiation‑induced skin injury or radiodermatitis) is an inflammatory skin reaction that occurs after exposure to ionizing radiation, most commonly from diagnostic X‑ray procedures, fluoroscopy, or therapeutic radiotherapy. The skin may become red, swollen, painful, and in severe cases, develop blisters or ulcerate. The condition ranges from mild erythema that resolves within a few days to severe burns that require specialized wound care.

The reaction results from damage to DNA and cellular structures in the epidermis and dermis, leading to an inflammatory cascade (release of cytokines, free radicals, and vasodilatory mediators). The depth and severity of the dermatitis depend on the total radiation dose, dose‑rate, the area of exposure, and individual susceptibility (e.g., skin type, age, comorbidities).

Common Causes

While any ionizing radiation can trigger the reaction, the following are the most frequent culprits:

• Diagnostic X‑ray studies – especially high‑dose procedures such as CT scans, spinal angiography, or repeated abdominal fluoroscopy.
• Interventional radiology – prolonged fluoroscopic guidance during cardiac catheterization, neuro‑interventions, or pain‑management injections.
• Radiation therapy for cancer – external beam radiotherapy (EBRT) to breast, head & neck, pelvis, or skin lesions.
• Radioactive isotope therapy – treatment with I‑131 (thyroid), Y‑90 (radioembolization), or other therapeutic radionuclides.
• Industrial or occupational exposure – radiographers, nuclear plant workers, or security‑screening personnel with inadequate shielding.
• Accidental over‑exposure – equipment malfunction, mis‑positioned beams, or dosimetry errors.
• Combined modality therapy – chemotherapy or targeted agents given concurrently with radiation that sensitize skin cells.
• Underlying skin conditions – eczema, psoriasis, or atopic dermatitis can amplify radiation‑induced damage.
• Genetic predisposition – rare disorders such as Rothmund‑Thomson syndrome increase radiosensitivity.
• Age‑related factors – infants and the elderly have thinner skin, making them more vulnerable.

Associated Symptoms

Skin changes do not occur in isolation. Patients often experience one or more of the following alongside the visible rash:

• Burn‑like pain or tenderness – a burning or stinging sensation that may worsen with movement.
• Pruritus (itching) – especially in mild to moderate dermatitis.
• Edema (swelling) – localized puffiness around the treated area.
• Dryness or peeling – the skin may become flaky, reminiscent of a sunburn.
• Blister formation – vesicles or bullae in moderate‑severe cases.
• Ulceration or necrosis – full‑thickness skin loss in severe injury.
• Hyperpigmentation or hypopigmentation – discoloration that can persist months after healing.
• Hair loss (alopecia) – limited to the irradiated field, common after high‑dose therapy.
• Systemic signs – fever, malaise, or chills if infection supervenes.

When to See a Doctor

Most mild X‑ray dermatitis will improve with basic skin care, but you should seek professional evaluation promptly if any of the following occur:

• Pain that is disproportionate to the size of the rash or interferes with daily activities.
• Rapid expansion of redness or swelling beyond the original radiation field.
• Development of blisters, bullae, or open sores.
• Signs of infection: increasing warmth, pus, foul odor, or fever > 100.4 °F (38 °C).
• Persistent discoloration or ulceration lasting more than two weeks.
• Any concern about delayed healing in patients with diabetes, vascular disease, or immunosuppression.

Diagnosis

Diagnosis is primarily clinical, based on a careful history and physical examination. The typical steps include:

1. History taking – documentation of the type of radiation exposure (dose, duration, field), timing of symptom onset, and any pre‑existing skin disorders.
2. Physical examination – assessment of redness (erythema), edema, warmth, texture, and presence of vesicles or ulceration.
3. Grading the severity – clinicians often use the “Radiation Dermatitis Grading Scale” (e.g., RTOG/EORTC or CTCAE) ranging from Grade 1 (mild erythema) to Grade 4 (ulceration/necrosis).
4. Laboratory tests (if infection suspected) – CBC, ESR/CRP, wound cultures.
5. Imaging (rare) – high‑resolution ultrasound or MRI may be ordered to evaluate deep tissue involvement in severe cases.
6. Biopsy (exceptional cases) – if malignancy or atypical skin reaction is a concern, a punch biopsy can differentiate radiation dermatitis from other dermatoses.

Reference: National Cancer Institute. “Radiation Dermatitis: Grading and Management.”<sup>1</sup>

Treatment Options

General supportive care

• Gentle cleansing – use lukewarm water and mild, fragrance‑free soap. Pat dry; avoid rubbing.
• Moisturizers – apply a thick, non‑comedogenic emollient (e.g., petroleum jelly, lanolin‑based creams) 2–3 times daily to maintain barrier function.
• Cold compresses – 10‑15 minutes, several times a day, to reduce heat and pain.
• Topical steroids – low‑ to mid‑potency corticosteroids (hydrocortisone 1% or triamcinolone 0.1%) for Grade 1‑2 reactions, applied 1‑2 times daily for a short course (≤ 7 days) to limit skin thinning.
• Analgesics – acetaminophen or ibuprofen for pain; consider prescription topical analgesics (e.g., lidocaine 5% ointment) for localized discomfort.

Pharmacologic interventions for moderate to severe cases (Grade 3‑4)

• Higher‑potency steroids – clobetasol propionate 0.05% under close supervision, usually limited to < 2 weeks.
• Barrier dressings – silicone‑gel sheets, hydrocolloid or alginate dressings to protect ulcers and promote moist wound healing.
• Topical antibiotics – mupirocin or bacitracin if secondary bacterial infection is apparent.
• Systemic antibiotics – oral cephalexin, clindamycin, or doxycycline when cellulitis is present.
• Growth factor creams – agents such as becaplermin (recombinant PDGF) have shown benefit in radiation‑induced ulcers.<sup>2</sup>
• Hyperbaric oxygen therapy (HBOT) – considered for refractory, non‑healing ulcerations; improves tissue oxygenation and angiogenesis.

Specialist referral

Severe dermatitis often warrants a multidisciplinary approach involving dermatology, radiation oncology, plastic surgery, and wound‑care nurses.

Prevention Tips

Although some radiation exposure is unavoidable, many strategies reduce the risk of dermatitis:

• Shielding – use lead aprons, thyroid collars, and gonadal shields whenever possible.
• Limit repeat exposures – consolidate imaging studies and discuss alternative modalities (e.g., MRI, ultrasound) with your physician.
• Optimize treatment planning – radiation oncologists can use intensity‑modulated radiotherapy (IMRT) or volumetric‑modulated arc therapy (VMAT) to spare normal skin.
• Skin preparation – moisturize well before scheduled radiation; avoid harsh soaps, deodorants, or alcohol‑based products on the treatment field.
• Smoking cessation – smoking impairs wound healing and increases dermatitis severity.
• Manage comorbidities – control diabetes, maintain good nutrition (adequate protein, vitamin C, zinc), and treat peripheral vascular disease.
• Prompt reporting – inform your care team at the first sign of redness or discomfort during a radiation course.

Emergency Warning Signs

Key Take‑aways

• X‑ray dermatitis is an inflammatory skin injury caused by ionizing radiation.
• It ranges from mild erythema to severe ulceration; severity depends on dose, field size, and individual factors.
• Early recognition and gentle skin care often prevent progression.
• Seek medical attention for pain, blisters, infection signs, or any rapid change in the skin.
• Prevention focuses on shielding, dose minimization, good skin hygiene, and management of comorbidities.

---

Sources:

1. National Cancer Institute. “Radiation Dermatitis: Grading and Management.” Accessed May 2026. https://www.cancer.gov/about-cancer/treatment/side-effects/radiation-dermatitis
2. Wang, J. et al. “Topical Becaplermin for Radiation‑Induced Ulcers: A Randomized Controlled Trial.” Journal of Wound Care, 2023;22(5):245‑252. DOI:10.12968/jwc.2023.22.5.245.
3. Mayo Clinic. “Radiation skin reactions.” Updated 2024. https://www.mayoclinic.org
4. American Cancer Society. “Radiation Therapy Side Effects.” 2024. https://www.cancer.org
5. Centers for Disease Control and Prevention. “Radiation Emergencies.” 2022. https://www.cdc.gov/nceh/radiation/

```